Unlimited Decentralized Financial Markets with Eric Chen, CEO of Injective Labs

February 23, 2022

Eric Chen is the CEO and Co-founder of Injective Labs, a fintech company focused on creating revolutionary Web3 products. Eric’s passion for crypto and blockchain started with mining Ethereum and participating in cryptographic research in college while studying finance and computer science.

After working at a major crypto hedge fund, he decided to drop out of college and founded Injective Labs together with Albert Chon (CTO). Injective Labs is the core contributor behind the decentralized exchange protocol Injective.

Injective is currently the fastest growing exchange platform reaching $1 Billion in trading volume within the first 30 days of release. For context, it took Coinbase a year to accomplish the same feat. Unlike Coinbase, Injective is entirely controlled by users meaning that all new markets are actually chosen by users. Injective collects zero revenue and uses any fee generated to be distributed back to their users via its unique decentralized token model.

See more recent cybersecurity episodes